QUIDEL CORP /DE/
8-K, 1998-03-05
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: IBM CREDIT CORP, 424B3, 1998-03-05
Next: GT INVESTMENT PORTFOLIOS INC, N-30D, 1998-03-05



<PAGE>   1





                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549


                                  -------------


                                    FORM 8-K


                                 CURRENT REPORT

                    Pursuant to Selection 13 or 15(d) of the
                         Securities Exchange Act of 1934


         Date of Report (Date of earliest event reported) March 2, 1998
                                                          -------------

                               QUIDEL CORPORATION
- --------------------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)


   Delaware                          0-10961                    94-2573850
- --------------------------------------------------------------------------------
(State or other                    (Commission                 (IRS Employer
jurisdiction of                    File Number)              Identification No.)
incorporation)


10165 McKellar Court San Diego, California                        92121
- --------------------------------------------------------------------------------
 (Address of principal executive offices)                       (Zip Code)


Registrant's telephone number, including area code   (619) 552-1100
                                                     --------------


                                       N/A
- --------------------------------------------------------------------------------
         (Former name or former address, if changed since last report)


<PAGE>   2

ITEM 5.  OTHER EVENTS.

         On March 2, 1998, Quidel Corporation, a Delaware corporation (the
"Company") announced that Steven T. Frankel has resigned as President and Chief
Executive Officer and as a director of the Company. The Company also announced
the commencement of an immediate search to evaluate potential candidates to fill
these positions. During the interim period, a four-person Executive Committee
has been authorized by the full Board of Directors to manage and direct the
operational aspects of the Company's business.

         Pursuant to General Instruction F of Form 8-K, the following document
is incorporated by reference herein and attached as an exhibit hereto:

         EXHIBIT          DESCRIPTION
         -------          -----------
            99            Quidel Corporation press release of March 2, 1998, 
                          announcing management transition

        Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

Date: March 5, 1998                         QUIDEL CORPORATION



                                            By: /s/ STEVEN C. BURKE
                                                --------------------------------
                                                Steven C. Burke
                                                Vice President-Finance and 
                                                Administration and Chief 
                                                Financial Officer




                                       2

<PAGE>   3

                                 EXHIBIT INDEX


EXHIBIT
NUMBER                  DESCRIPTION
- -------                 -----------
  99                    Quidel Corporation press release of March 2, 1998,
                        announcing management transition



<PAGE>   1
                                                                      EXHIBIT 99


FOR IMMEDIATE RELEASE                                   CONTACT: Steven C. Burke
                                                              Quidel Corporation
                                                                  (619) 552-7960


                                QUIDEL ANNOUNCES
                              MANAGEMENT TRANSITION

        San Diego, California, March 2, 1998-- QUIDEL Corp. (Nasdaq:QDEL)
announced today that Steven T. Frankel has resigned as President and Chief
Executive Officer and as a director of the Company. QUIDEL also announced the
commencement of an immediate search to evaluate potential candidates to fill
these positions. During the interim period, a four-person Executive Committee
has been authorized by the full Board of Directors to manage and direct the
operational aspects of QUIDEL's business.

        Mr. Frankel originally joined QUIDEL in June 1992 with over 25 years of
broad operating experience within the healthcare industry. He assumed the role
of Chief Executive Officer in May 1994.

        Richard C.E. Morgan, Chairman of QUIDEL, noted: "We are deeply
appreciative of Steven's leadership and successes over the past six years and
wish him every success in the future. Steven was instrumental during this period
in QUIDEL's achievement of profitability and significant revenue growth. QUIDEL
looks forward to building further upon the foundation which has now been
established."

        QUIDEL Corporation discovers, develops, manufacturers and markets rapid
immunodiagnostic products for point-of-care detection of human medical
conditions and illnesses. These products provide simple, accurate and
cost-effective diagnoses for acute and chronic conditions in the areas of
reproductive and women's health, infectious diseases, allergies and autoimmune
disorders. QUIDEL's products are sold to professionals in the physician's office
and clinical laboratory, and to consumers through retail drug stores.
QUIDEL is based in San Diego, California.

        This press release contains forward-looking statements regarding QUIDEL
and its future activities. Actual results could differ materially from those
described or implied in this press release as a result of a number of factors.
For more information about QUIDEL, go to http://www.quidel.com.




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission